CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
H2MFdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03214822
NCT03214822N/ACompleted
CompareCT.gov

The Impact of Human-derived Human Milk Fortifiers (H2MF) on Gut Microbiota Development and Oxidative Stress in Premature Infants

University of Manitoba·interventional·Posted Jul 12, 2017·Updated Sep 30, 2019

In Brief

A clinical study evaluating H2MF for Very Low Birth Weight Baby and 3 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This is a randomized controlled trial of a human-derived human milk fortifier (H2MF) vs standard bovine-derived human milk fortifier (HMF) evaluating fecal microbiota and fecal and urinary biomarkers of oxidative stress in premature infants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVery Low Birth Weight Baby, Premature Birth, Microbial Colonization, Oxidative Stress
CountriesCanada
CollaboratorsManitoba Developmental Origins of Chronic Diseases in Children Network (DEVOTION), Prolacta Bioscience, Children's Hospital Foundation

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 12, 2017
Enrollment StartAug 1, 2017
Primary CompletionJul 30, 2019
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 9.0 years ago

Interventions

H2MFdietary

As described in the Experimental Arm description.